Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 3
2005 4
2006 9
2007 4
2008 11
2009 5
2010 13
2011 14
2012 20
2013 12
2014 11
2015 9
2016 9
2017 13
2018 23
2019 21
2020 29
2021 23
2022 28
2023 17
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

255 results

Results by year

Filters applied: . Clear all
Page 1
Potentiating Activity of GmhA Inhibitors on Gram-Negative Bacteria.
Moreau F, Atamanyuk D, Blaukopf M, Barath M, Herczeg M, Xavier NM, Monbrun J, Airiau E, Henryon V, Leroy F, Floquet S, Bonnard D, Szabla R, Brown C, Junop MS, Kosma P, Gerusz V. Moreau F, et al. Among authors: brown c. J Med Chem. 2024 Apr 25;67(8):6610-6623. doi: 10.1021/acs.jmedchem.4c00037. Epub 2024 Apr 10. J Med Chem. 2024. PMID: 38598312 Free PMC article.
A second hotspot for pathogenic exon-skipping variants in CDC45.
Schoch K, Ruegg MSG, Fellows BJ, Cao J, Uhrig S, Einsele-Scholz S, Biskup S, Hawarden SRA, Salpietro V, Capra V; Undiagnosed Diseases Network; Brown CM, Accogli A, Shashi V, Bicknell LS. Schoch K, et al. Among authors: brown cm. Eur J Hum Genet. 2024 Mar 11. doi: 10.1038/s41431-024-01583-1. Online ahead of print. Eur J Hum Genet. 2024. PMID: 38467731
A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE.
Tan L, Brown C, Mersiades A, Lee CK, John T, Kao S, Newnham G, O'Byrne K, Parakh S, Bray V, Jasas K, Yip S, Wong SQ, Ftouni S, Guinto J, Chandrashekar S, Clarke S, Pavlakis N, Stockler MR, Dawson SJ, Solomon BJ. Tan L, et al. Among authors: brown c. Nat Commun. 2024 Feb 28;15(1):1823. doi: 10.1038/s41467-024-46008-1. Nat Commun. 2024. PMID: 38418463 Free PMC article. Clinical Trial.
First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study.
Brown LJ, Khou V, Brown C, Alexander M, Jayamanne D, Wei J, Gray L, Chan WY, Smith S, Harden S, Mersiades A, Warburton L, Itchins M, Lee JH, Pavlakis N, Clarke SJ, Boyer M, Nagrial A, Hau E, Pires da Silva I, Kao S, Kong BY. Brown LJ, et al. Among authors: brown c. Front Oncol. 2024 Feb 7;14:1305720. doi: 10.3389/fonc.2024.1305720. eCollection 2024. Front Oncol. 2024. PMID: 38406805 Free PMC article.
Development of clinically meaningful quality indicators for contemporary lung cancer care, and piloting and evaluation in a retrospective cohort; experiences of the Embedding Research (and Evidence) in Cancer Healthcare (EnRICH) Program.
Brown B, Galpin K, Simes J, Boyer M, Brown C, Chin V, Young J; Clinical Advisory Group. Brown B, et al. Among authors: brown c. BMJ Open. 2024 Feb 14;14(2):e074399. doi: 10.1136/bmjopen-2023-074399. BMJ Open. 2024. PMID: 38355175 Free PMC article.
Feasibility of Symptom monitoring WIth Feedback Trial (SWIFT) for adults on hemodialysis: a registry-based cluster randomized pilot trial.
Agarwal N, Shah KK, Dansie K, Bennett PN, Greenham L, Brown C, Smyth B, McDonald S, Jesudason S, Viecelli AK, Morton RL; Symptom monitoring With Feedback Trial (SWIFT) Investigators. Agarwal N, et al. Among authors: brown c. BMC Nephrol. 2023 Nov 22;24(1):345. doi: 10.1186/s12882-023-03399-5. BMC Nephrol. 2023. PMID: 37993776 Free PMC article. Clinical Trial.
255 results